Amos CI - Search Results

1

Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome.

Wei C, Amos CI, Rashid A, Sabripour M, Nations L, McGarrity TJ, Frazier ML. Wei C, et al. Among authors: amos ci. J Histochem Cytochem. 2003 Dec;51(12):1665-72. doi: 10.1177/002215540305101210. J Histochem Cytochem. 2003. PMID: 14623934

2

Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome.

McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK. McGarrity TJ, et al. Among authors: amos ci. Am J Gastroenterol. 2003 Mar;98(3):671-8. doi: 10.1111/j.1572-0241.2003.07328.x. Am J Gastroenterol. 2003. PMID: 12650805

3

Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

Frazier ML, Xi L, Zong J, Viscofsky N, Rashid A, Wu EF, Lynch PM, Amos CI, Issa JP. Frazier ML, et al. Among authors: amos ci. Cancer Res. 2003 Aug 15;63(16):4805-8. Cancer Res. 2003. PMID: 12941799

4

Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.

Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Gorlov IP, et al. Among authors: amos ci. Am J Hum Genet. 2003 Nov;73(5):1157-61. doi: 10.1086/378819. Epub 2003 Oct 1. Am J Hum Genet. 2003. PMID: 14526391 Free PMC article.

5

GSTM1 polymorphism does not affect hereditary nonpolyposis colorectal cancer age of onset.

Jones JS, Gu X, Campos IM, Lynch PM, Amos CI, Frazier ML. Jones JS, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):676-8. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066938 No abstract available.

6

p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.

Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. Jones JS, et al. Among authors: amos ci. Clin Cancer Res. 2004 Sep 1;10(17):5845-9. doi: 10.1158/1078-0432.CCR-03-0590. Clin Cancer Res. 2004. PMID: 15355915

7

Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).

Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Gorlov IP, et al. Among authors: amos ci. Mutat Res. 2004 Oct 4;554(1-2):175-83. doi: 10.1016/j.mrfmmm.2004.04.014. Mutat Res. 2004. PMID: 15450416

8

The hamartomatous polyposis syndromes: a clinical and molecular review.

Schreibman IR, Baker M, Amos C, McGarrity TJ. Schreibman IR, et al. Am J Gastroenterol. 2005 Feb;100(2):476-90. doi: 10.1111/j.1572-0241.2005.40237.x. Am J Gastroenterol. 2005. PMID: 15667510 Review.

9

Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM. Gritz ER, et al. Among authors: amos ci. J Clin Oncol. 2005 Mar 20;23(9):1902-10. doi: 10.1200/JCO.2005.07.102. J Clin Oncol. 2005. PMID: 15774782

10

ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).

Jones JS, Gu X, Lynch PM, Rodriguez-Bigas M, Amos CI, Frazier ML. Jones JS, et al. Among authors: amos ci. Cancer Causes Control. 2005 Aug;16(6):749-53. doi: 10.1007/s10552-005-1540-7. Cancer Causes Control. 2005. PMID: 16049814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

863 results

Search Page

Filters